Diplomat Announces 1st Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Diplomat Pharmacy (DPLO) PT Raised to $17 at Cowen; Reiterates Market Perform
May 9, 2017 8:11 AM EDTCowen raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $17.00 (from $12.00) while maintaining a Market Perform rating. DPLO reported 1Q revenues of $1.08B, which was in-line with consensus, due to acquisitions, manufacturing price increases and contributions from new drugs. Adjusted EPS of $0.19 also exceeded... More
Diplomat Pharmacy (DPLO) Tops Q1 EPS by 4c, Offers FY Guidance
May 8, 2017 4:22 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.08 billion.
GUIDANCE:
Diplomat Pharmacy sees FY2017 EPS of $0.54-$0.74, versus the consensus of... More
